Crystal structure of a pentamidine-oligonucleotide complex: implications for DNA-binding properties

Area of Science:

• Structural Biology
• Medicinal Chemistry
• Molecular Biophysics

Background:

• Pentamidine is an effective drug against Pneumocystis carinii, a pathogen causing opportunistic infections in AIDS patients.
• Understanding the molecular interactions of pentamidine with DNA is essential for drug development and efficacy.

Purpose of the Study:

• To determine the high-resolution crystal structure of the complex formed between the dodecanucleotide d(CGCGAATTCGCG)2 and pentamidine.
• To elucidate the specific binding mode and interactions of pentamidine within the DNA minor groove.

Main Methods:

• X-ray crystallography was employed to determine the structure of the pentamidine-DNA complex.
• High-resolution data (2.1 A) and an R-factor of 19.4% were achieved for the crystal structure analysis.

Main Results:

• Pentamidine binds to the 5 zez'-AATT minor groove region of the DNA duplex.
• The drug adopts an extended conformation, with amidinium groups forming interstrand hydrogen bonds to adenine N3 atoms.
• The binding site spans approximately four base pairs, detailing specific drug-DNA interactions.

Conclusions:

• The determined crystal structure provides detailed insights into the molecular basis of pentamidine-DNA binding.
• This structural information can guide the design of new pentamidine analogs with improved efficacy or altered binding properties.
• Comparison with the berenil ligand complex offers further understanding of structure-activity relationships for minor groove binders.